We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
Cap. Flow
+$9.28B
Cap. Flow %
7.32%
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.86B
2
COST icon
Costco
COST
+$907M
3
ABBV icon
AbbVie
ABBV
+$643M
4
JPM icon
JPMorgan Chase
JPM
+$609M
5
BAC icon
Bank of America
BAC
+$567M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.03B
2
MELI icon
Mercado Libre
MELI
+$528M
3
AVGO icon
Broadcom
AVGO
+$514M
4
SNDK
Sandisk
SNDK
+$507M
5
MRVL icon
Marvell Technology
MRVL
+$499M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.91%
2 Technology 20.64%
3 Consumer Discretionary 9.1%
4 Healthcare 8.21%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
L icon
3451
Loews
L
$22.1B
-2,000
Closed -$213K
LASR icon
3452
nLIGHT
LASR
$2.4B
-138,049
Closed -$7.87M
LCID icon
3453
Lucid Motors
LCID
$1.82B
-923,777
Closed -$5.96M
LCUT icon
3454
Lifetime Brands
LCUT
$205M
-11,612
Closed -$66.7K
LDOS icon
3455
Leidos
LDOS
$16.2B
-17,790
Closed -$2.77M
LEE icon
3456
Lee Enterprises
LEE
$171M
-23,561
Closed -$203K
LEG
3457
DELISTED
Leggett & Platt
LEG
-1,169,326
Closed -$11.6M
LGND icon
3458
Ligand Pharmaceuticals
LGND
$5.76B
-7,505
Closed -$1.5M
LMND icon
3459
CALL
Lemonade
LMND
$3.91B
-800
Closed -$50.1K
LMNR icon
3460
Limoneira
LMNR
$273M
-12,796
Closed -$172K
LODE icon
3461
Comstock
LODE
$234M
-449,906
Closed -$1.37M
LPTH icon
3462
Lightpath Technologies
LPTH
$675M
-82,010
Closed -$823K
LSTR icon
3463
Landstar System
LSTR
$6.02B
-3,222
Closed -$517K
LTRX icon
3464
Lantronix
LTRX
$246M
-458,745
Closed -$2.4M
LUMN icon
3465
PUT
Lumen
LUMN
$6.85B
-1,300
Closed -$9.04K
LXFR icon
3466
Luxfer Holdings
LXFR
$463M
-126,059
Closed -$1.54M
LXRX icon
3467
Lexicon Pharmaceuticals
LXRX
$992M
-2,376,304
Closed -$3.71M
LYB icon
3468
LyondellBasell Industries
LYB
$20.9B
-14,885
Closed -$1.03M
LYFT icon
3469
CALL
Lyft
LYFT
$6.15B
-2,800
Closed -$37.2K
LYFT icon
3470
PUT
Lyft
LYFT
$6.15B
-16,600
Closed -$221K
LYTS icon
3471
LSI Industries
LYTS
$729M
-11,173
Closed -$208K
LYV icon
3472
PUT
Live Nation Entertainment
LYV
$39.7B
-70,000
Closed -$10.7M
M icon
3473
PUT
Macy's
M
$5.91B
-2,400
Closed -$43.4K
MAA icon
3474
Mid-America Apartment Communities
MAA
$14.8B
-168,206
Closed -$20.5M
MAGS icon
3475
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.24B
-39,367
Closed -$2.28M

Similar funds

Marshall Wace's Q2 2026 Portfolio in Review

As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.

  • Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
  • Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
  • Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
  • Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
  • Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
  • Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.